| First Author | Qiao Y | Year | 2019 |
| Journal | Biochem Biophys Res Commun | Volume | 514 |
| Issue | 2 | Pages | 372-378 |
| PubMed ID | 31043271 | Mgi Jnum | J:291113 |
| Mgi Id | MGI:6442907 | Doi | 10.1016/j.bbrc.2019.04.144 |
| Citation | Qiao Y, et al. (2019) Hepatocellular iNOS protects liver from NASH through Nrf2-dependent activation of HO-1. Biochem Biophys Res Commun 514(2):372-378 |
| abstractText | Multiple molecular events are involved in non-alcoholic steatohepatitis (NASH). There is no consensus on the role of inducible nitric oxide synthase (iNOS) in the progression of NASH. The present study therefore investigated the role of iNOS in NASH pathogenesis using bone marrow-transplanted iNOS chimeric mice under high-fat diet (HFD) conditions. The chimeric mice were fed a HFD for 16wk, and primary hepatocytes were stimulated with oleic acid (OA). The molecular mechanisms underlying the role of iNOS in NASH were investigated. Marked hepatic steatosis and injury observed in the HFD mice and OA-stimulated hepatocytes were reduced by hepatocyte-derived iNOS. Mechanistically, iNOS upregulated heme oxygenase 1 (HO-1) by augmenting nuclear factor erythroid 2-related factor 2 (Nrf-2) binding to the HO-1 gene promoter. In conclusion, hepatocyte-derived iNOS may play a protective role against the progression of NASH by upregulating HO-1 through Nrf-2. Upregulation of hepatocellular iNOS may represent a potentially new therapeutic paradigm to combat NASH. |
